Skip to main content
. 2011 Jul;55(7):3240–3243. doi: 10.1128/AAC.01680-10

Table 1.

Demographics and pharmacokinetic parameters

Demographic or pharmacokinetic parametera Mean ± SDb
Ambulatory (n = 3) Hospitalized (n = 12) Total (n = 15) Normal wt in 2001 (n = 4)e
Demographics
    Age (yr) 35.3 ± 12.5 41.5 ± 11.8 38.4 ± 12.8 NR
    % Male 67 50 53 NR
    Wt (kg) 113.3 ± 12.3 161.9 ± 67.1 145.5 ± 59.4 NR
    BMI (kg/m2) 37.4 ± 5.9 54.8 ± 23.5 49.3 ± 20.7 NR
    Obese classc
        Obese class I (n) 1 1 2 NR
        Obese class II (n) 1 3 4 NR
        Obese class III (n) 1 8 9 NR
    SCR (mg/dl) 0.8 ± 0.1 1.0 ± 0.3 0.98 ± 0.2 NR
    CLCR (ml/min)
        Estimated (Salazar-Corcoran) 80.1 ± 13 99.2 ± 57.8 86.1 ± 41.8 NR
        Estimated (Cockroft-Gault/BSA) 87.2 ± 11.7 82.2 ± 41.1 83.1 ± 36.9 NR
        Measured 184.3 ± 20.8d 135.6 ± 71 140.7 ± 64.4 NR
Pharmacokinetics
    Cmax (mg/liter) 7.84 ± 0.99 8.4 ± 1.8 8.2 ± 1.8 8.12 ± 0.99
    Ke (h−1) 0.264 ± 0.069 0.100 ± 0.062 0.117 ± 0.0697 NR
    Half-life (h) 2.63 ± 0.687 6.93 ± 4.27 5.92 ± 3.53 6.91 ± 0.83
    Vol of distribution (liters) 79.4 ± 12.8 82.7 ± 20.5 83.8 ± 21.6 106 ± 12
    Vol of distribution (liters/kg [ABW]) 0.7 ± 0.11 0.51 ± 0.13 0.58 ± 0.15 NR
    Vol of distribution (liters/kg [IBW]) 1.2 ± 0.36 1.4 ± 0.76 1.3 ± 0.69 NR
    Systemic clearance (ml/min) 348.8 ± 3.5 139.7 ± 70.4 163.3 ± 70.45 186 ± 5
    AUC0–24 (mg/liter·h) 36.8 ± 6.4 90.12 ± 40.8 76.55 ± 32.96 61.1 ± 1.3
a

BMI, body mass index; CLCR, creatinine clearance; SCR, serum creatinine; ABW, actual body weight; IBW, ideal body weight (9).

b

All values are reported as means ± the standard deviation except as noted in column 1. NR, not reported.

c

Obese class I, BMI 30 to 35; class II, BMI 35 to 40; class III, BMI >40 (24).

d

P < 0.05 measured versus the estimated CLCR determined by the Salazar-Corcoran method and by the Cockcroft-Gault method standardized using the body surface area (BSA).

e

According to Chow et al. (7).